246 results on '"Jonas, Jeffrey"'
Search Results
2. Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder
3. Exploring the ENSO modulation of the QBO periods with GISS E2.2 models
4. Hurricanes and Climate: The U.S. CLIVAR Working Group on Hurricanes
5. Characteristics of tropical cyclones in high‐resolution models in the present climate
6. Atmospheric Response to a Collapse of the North Atlantic Circulation under a Mid-Range Future Climate Scenario: A Regime Shift in Northern Hemisphere Dynamics
7. Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial
8. Atmospheric Response to a Collapse of the North Atlantic Circulation Under A Mid-Range Future Climate Scenario: A Regime Shift in Northern 2 Hemisphere Dynamics
9. ENSO Modulation of the QBO Periods in GISS E2.2 Models
10. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
11. Trial of SAGE-217 in Patients With Major Depressive Disorder
12. Zuranolone in Major Depressive Disorder
13. An Assessment of Multimodel Simulations for the Variability of Western North Pacific Tropical Cyclones and Its Association with ENSO
14. Brexanolone Injection in Postpartum Depression: Two Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trials
15. CORRECTION: HURRICANES AND CLIMATE: THE U.S. CLIVAR WORKING GROUP ON HURRICANES
16. Symmetric Equations on the Surface of a Sphere as Used by Model GISS:IB
17. Tracking Scheme Dependence of Simulated Tropical Cyclone Response to Idealized Climate Simulations
18. How Well Do Global Climate Models Simulate the Variability of Atlantic Tropical Cyclones Associated with ENSO?
19. The Impact of Different Absolute Solar Irradiance Values on Current Climate Model Simulations
20. ENSO Modulation of the QBO Periods in GISS E2.2 Models.
21. Climate responses to SATIRE and SIM-based spectral solar forcing in a 3D atmosphere-ocean coupled GCM
22. The PlioMIP2 Mid-Pliocene Climate Simulations Using the NASA-GISS ModelE
23. Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder
24. A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression
25. Cumulus Microphysics and Climate Sensitivity
26. Tropical Cyclones in the GISS ModelE2
27. Do Substance-Abuse, Including Alcoholism, and Bulimia Covary?
28. Naltrexone and Bulimia: Initial Observations
29. Effect of Zuranolone vs Placebo in Postpartum Depression
30. A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults
31. Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial
32. Zuranolone in Major Depressive Disorder: Interim Efficacy Results From a Phase 3, Open-Label, Longitudinal Study
33. Zuranolone in Major Depressive Disorder: Interim Safety Results From a Phase 3, Open-Label, Longitudinal Study
34. The QBO in Two GISS Global Climate Models: 1. Generation of the QBO
35. The Role of Long-Lived Greenhouse Gases as Principal LW Control Knob that Governs the Global Surface Temperature for Past and Future Climate Change
36. GISS Model E2.2: A Climate Model Optimized for the Middle Atmosphere—2. Validation of Large‐Scale Transport and Evaluation of Climate Response
37. How Well Do Global Climate Models Simulate the Variability of Atlantic Tropical Cyclones Associated with ENSO?
38. A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of SAGE-217 in the Treatment of Adult Patients With Major Depressive Disorder
39. 934: Phase 3, randomized, placebo-controlled trial of SAGE-217 in postpartum depression: Association between HAM-D and PHQ-9
40. A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults.
41. Memantine in the Treatment of Binge Eating Disorder: An Open-Label, Prospective Trial
42. Pharmacotherapy and Behavioral Intervention for Alcohol Dependence
43. Trial of SAGE-217 in Patients with Major Depressive Disorder
44. T111. Patient-Reported Health-Related Quality of Life Correlates Inversely With Depressive Symptoms in a Pivotal Trial of SAGE-217 in Major Depressive Disorder
45. Fluvoxamine in the Treatment of Binge-Eating Disorder: A Multicenter Placebo-Controlled, Double-Blind Trial
46. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
47. Symmetric Equations on the Surface of a Sphere as Used by Model GISS:IB
48. O46. SAGE-217 a First in Class GABAA Receptor Positive Allosteric Modulator in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Phase 2 Placebo-Controlled Trial
49. Triazolam
50. Triazolam
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.